Literature DB >> 6254049

Appearance of cytoskeletal components on the surface of leukemia cells and of lymphocytes transformed by mitogens and Epstein-Barr virus.

R J Bachvaroff, F Miller, F T Rapaport.   

Abstract

Lactoperoxidase iodination and two-dimensional electrophoresis of the labeled proteins have demonstrated well-characterized cytoskeletal proteins (actin and tubulins) on the surface of human lymphocytes undergoing blastogenic transformation and of certain malignant human cells. Such proteins could not be detected on the surface of normal resting human lymphocytes. The most prominent cytoskeletal protein identified on the surface membrane of mitogen-transformed T and B lymphocytes was actin. In Epstein-Barr virus genome-positive Burkitt's lymphoma and lymphoblastoid cell lines and in two leukemia cells, the major iodinated membrane protein components were actin and alpha 1-, alpha 2-, and beta-tubulins. These proteins were firmly connected to the cytoplasmic skeleton and could not be removed by Triton X-100. Concurrent immunofluorescence studies with specific antibodies and F(ab')2 fragments confirmed the appearance of cytoskeletal components on the biochemical data, and indicated that such cytoskeletal proteins formed distinctive patterns on the cell surface, ranging from small patches to large projections. Five-hour labeling with [35S]methionine indicates that all such cells released large quantities of labeled actin and tubulins into the culture medium. These materials were not readsorbed to the membrane surfaces of the cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254049      PMCID: PMC349973          DOI: 10.1073/pnas.77.8.4979

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Platelet thrombosthenin: subcellular localization and function.

Authors:  R L Nachman; A J Marcus; L B Safier
Journal:  J Clin Invest       Date:  1967-08       Impact factor: 14.808

2.  Microtubule assembly in the absence of added nucleotides.

Authors:  M L Shelanski; F Gaskin; C R Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

3.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

4.  An association between actin and the major histocompatibility antigen H-2.

Authors:  G L Koch; M J Smith
Journal:  Nature       Date:  1978-05-25       Impact factor: 49.962

5.  Actin may be present on the lymphocyte surface.

Authors:  M J Owen; J Auger; B H Barber; A J Edwards; F S Walsh; M J Crumpton
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

6.  Studies of mechanisms of antibody formation. III. Effects of 5-bromodeoxyuridine upon normal and neoplastic B-lymphocyte function.

Authors:  R J Bachvaroff; F T Rapaport
Journal:  Cell Immunol       Date:  1977-06-01       Impact factor: 4.868

7.  Active secretion of cytoskeletal and mechanochemical proteins in EBV-genome-positive human lymphocytes.

Authors:  R J Bachvaroff; F T Rapaport
Journal:  Transplant Proc       Date:  1980-03       Impact factor: 1.066

8.  Major membrane protein differences in cilia and flagella: evidence for a membrane-associated tubulin.

Authors:  R E Stephens
Journal:  Biochemistry       Date:  1977-05-17       Impact factor: 3.162

9.  Smooth muscle autoantibodies in infectious mononucleosis.

Authors:  E J Holborow; E H Hemsted; S V Mead
Journal:  Br Med J       Date:  1973-08-11

10.  Interaction of microtubule proteins with phospholipid vesicles.

Authors:  J M Caron; R D Berlin
Journal:  J Cell Biol       Date:  1979-06       Impact factor: 10.539

View more
  15 in total

Review 1.  The pivotal position of the actin cytoskeleton in the initiation and regulation of B cell receptor activation.

Authors:  Wenxia Song; Chaohong Liu; Arpita Upadhyaya
Journal:  Biochim Biophys Acta       Date:  2013-07-23

Review 2.  Proteins in unexpected locations.

Authors:  N R Smalheiser
Journal:  Mol Biol Cell       Date:  1996-07       Impact factor: 4.138

Review 3.  Emergent complexity of the cytoskeleton: from single filaments to tissue.

Authors:  F Huber; J Schnauß; S Rönicke; P Rauch; K Müller; C Fütterer; J Käs
Journal:  Adv Phys       Date:  2013-03-06       Impact factor: 25.375

4.  Heterogeneic autoantibody against neurofilament protein in the sera of animals with experimental kuru and Creutzfeldt-Jakob disease and natural scrapie infection.

Authors:  T Aoki; C J Gibbs; J Sotelo; D C Gajdusek
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

5.  Enhanced expression of Epstein-Barr virus early antigens by antitubulin agents in a latently infected human lymphoblastoid cell line.

Authors:  J Fujita; O Yoshida; H Tokuda; K Sugawara; Y Ito
Journal:  Experientia       Date:  1985-03-15

Review 6.  Subversion of the actin cytoskeleton during viral infection.

Authors:  Matthew P Taylor; Orkide O Koyuncu; Lynn W Enquist
Journal:  Nat Rev Microbiol       Date:  2011-04-27       Impact factor: 60.633

7.  The actin cytoskeleton coordinates the signal transduction and antigen processing functions of the B cell antigen receptor.

Authors:  Chaohong Liu; Margaret K Fallen; Heather Miller; Arpita Upadhyaya; Wenxia Song
Journal:  Front Biol (Beijing)       Date:  2013-10

8.  Actin and tubulin of normal and leukaemic lymphocytes.

Authors:  H Atkins; P J Anderson
Journal:  Biochem J       Date:  1982-12-01       Impact factor: 3.857

9.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.

Authors:  R M Chicz; R G Urban; J C Gorga; D A Vignali; W S Lane; J L Strominger
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

10.  Evidence for tubulin-binding sites on cellular membranes: plasma membranes, mitochondrial membranes, and secretory granule membranes.

Authors:  F Bernier-Valentin; D Aunis; B Rousset
Journal:  J Cell Biol       Date:  1983-07       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.